Atovaquone Suspension
Product Images NDC 60687-534

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 60687-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atovaquonestructure)

Chemical structure of Atovaquone, depicting its molecular composition with a naphthoquinone core, a cyclohexane ring, and a chlorophenyl group, consistent with the active ingredient in Atovaquone oral suspension 750 mg/5mL by American Health Packaging.*

FDA Label Image

Cup Label (Cup)

Atovaquone Oral Suspension USP label by American Health Packaging showing 750 mg per 5 mL strength. The label indicates dispensing information including the 5 mL delivery volume, instructions to not freeze and to shake gently before use, and that it is for institutional use only. The label also includes the NDC 60687-534 and a barcode.*

FDA Label Image

Tray Label (Tray)

A text panel for Atovaquone Oral Suspension, USP, labeled for institutional use only. It includes storage instructions to keep the suspension between 15°C to 25°C (59°F to 77°F), with warnings not to freeze and to shake gently before use. The panel also indicates the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.